AUPH
Aurinia Pharmaceuticals Inc
16.60$
+1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.3% | -5.7% | +1.3% | +4.9% | +0.2% | -8.3% | -0.5% | +5.0% | +42.5% | -3.7% | +9.4% | |
| – | -0.4% | -6.3% | +2.9% | +7.5% | +1.4% | -9.1% | +0.8% | +7.3% | +12.1% | -2.4% | +12.7% | |
| – | +5.3% | +31.9% | -48.2% | +11.2% | +124.6% | -20.4% | -20.2% | +38.1% | +9.6% | -48.9% | +338.5% | |
| – | +3.7% | -8.7% | +3.3% | +5.5% | +2.8% | -12.7% | +0.7% | +11.6% | +13.1% | -4.8% | +17.0% | |
| – | -36.5% | +20.0% | -11.7% | +42.9% | +0.2% | +10.4% | -0.6% | -22.9% | +34.0% | +18.6% | -16.3% | |
| – | +21.0% | +0.1% | -2.3% | -0.4% | +1.3% | +17.8% | +0.7% | -3.7% | +2.0% | +1.6% | -2.7% | |
| – | -5.4% | -4.4% | -2.9% | -2.4% | -3.4% | -4.5% | -2.7% | -3.6% | -3.6% | -4.5% | -5.9% | |
| – | +4.3% | -7.6% | +1.1% | +1.5% | +7.3% | -10.7% | +8.1% | -3.3% | +5.3% | -8.2% | +13.4% | |
| – | +4.5% | -7.9% | +8.2% | +2.2% | +24.4% | -30.0% | +14.4% | -2.6% | +23.0% | -7.6% | +15.4% | |
| – | +9.0% | -5.6% | +1.3% | +6.9% | -5.5% | +3.1% | +10.7% | +0.9% | +1.3% | +3.1% | -9.2% | |
| – | -51.1% | +31.1% | +48.4% | +5.5% | -41.6% | -18.6% | -21.5% | -33.2% | +49.6% | -19.7% | -34.8% | |
| – | -3.6% | -4.9% | +1.4% | +6.4% | -2.7% | -7.2% | -4.3% | +9.1% | +58.9% | -2.4% | +8.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +0.1% | +0.1% | +1.1% | +1.4% | -5.9% | +3.1% | -5.0% | +2.0% | -0.8% | -3.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.